Ruijing Investment
VC Fund
Ruijing Investment is a VC fund focused on Biotechnology and Medical.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Ruijing Investment invests in
Stages Ruijing Investment invests in
Countries Ruijing Investment invests in
Investment Focus
Industry
- Biotechnology 2 (67%)
- Medical 1 (33%)
- Genetics 1 (33%)
- Software 1 (33%)
- Health Care 1 (33%)
Stage
- Seed 2 (67%)
- Series A 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Dao Bio-Link
|
Dao Biolink is an information system integration and Internet of Things technology service provider. | $14.9M / Series A / May 25, 2022 | |
Gene Vector
|
Chengdu Genevector Biotechnology Co., Ltd. (Genevector, Genevector) is a biotechnology company engaged in the research and development of new drugs for adeno-associated virus (AAV) gene therapy. The company is committed to the development of new AAV gene therapy drugs for ophthalmic diseases, neuromuscular diseases, genetic and metabolic diseases,etc. | $3.2M / Seed / Mar 10, 2022 | |
NeoImmune
|
Universal Medicine is a technology developer in the field of immune system, dedicated to the development of key technologies for high-throughput reading and writing of T and B lymphocyte receptor profiles and their applications in clinical testing and treatment, focusing on technology developers in the field of immune system . Recently announcedthe completion of a 30 million RMB Pre-A round of strategic financing. WinX Capital is acting as a financial advisor. This round of investment was initiated by Kangsheng Global. Ruijiang Kangsheng Fund managed by Ruijiang Investment led the investment. The investors included Spark Venture Capital and Yangtze River Source Fund. This round of funds will be mainly used for the promotion of hematological tumor MRD products and the research and development of new clinical products. | $4.7M / Seed / Nov 25, 2021 |
Co-Investors
Kindstar Global (Beijing) Medicine Technology
2 deals together
Ming capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Ruijing Investment invest in?
Ruijing Investment invests primarily in Biotechnology, Medical and Genetics startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Ruijing Investment last invest?
The most recent investment recorded for Ruijing Investment closed in May 2022. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
